Physician profile
Munif Salek
NPI 1891890901
$14,058.68
in general payments reported to CMS, 2019-2025
47 companies · $2,313 in 2025
The $2,313 reported for 2025 was more than what 78% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,310 · 2020: $1,099 · 2021: $1,923 · 2022: $2,229 · 2023: $2,642 · 2024: $2,543 · 2025: $2,313.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,997 · Education: $501.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,997.08 |
| Education | $500.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $2,340.54 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals LP | $2,023.83 | 2019-2025 | Fasenra, Breztri, Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,488.97 | 2019-2025 | Ofev, Jascayd, Spiriva Respimat |
| Actelion Pharmaceuticals US, INC. | $1,215.28 | 2019-2025 | Uptravi, Opsumit |
| Regeneron Healthcare Solutions, INC. | $855.28 | 2019-2025 | Dupixent |
| Takeda Pharmaceuticals U.S.A., INC. | $808.30 | 2021-2025 | Glassia |
| Genzyme Corporation | $664.55 | 2019-2025 | |
| United Therapeutics Corporation | $547.88 | 2019-2023 | Tyvaso |
| Merck Sharp & Dohme LLC | $449.68 | 2019-2025 | Winrevair, Keytruda |
| Grifols USA, LLC | $316.70 | 2020-2025 | Prolastin-C Liquid |
| Insmed, INC. | $263.47 | 2019-2025 | Arikayce, Brinsupri |
| Sanofi-Aventis U.S. LLC | $259.44 | 2022-2024 | |
| Mylan Specialty L.P. | $237.19 | 2019-2024 | Yupelri |
| Philips North America LLC | $182.99 | 2019-2025 | Encore |
| Bayer Healthcare Pharmaceuticals INC. | $178.74 | 2019-2024 |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $170.46 | 2021-2023 | Xarelto |
| Ani Pharmaceuticals, INC. | $161.74 | 2025 | Purified Cortrophin Gel |
| Genentech USA, INC. | $159.59 | 2019-2023 | Xolair |
| Advanced Respiratory, INC | $151.92 | 2019-2021 | |
| Verona Pharma, INC. | $148.98 | 2025 | Ohtuvayre |
| Shionogi INC | $143.52 | 2024-2025 | Fetroja |
| Pulmonx Corporation | $122.04 | 2019-2023 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Chartis Catheter |
| Abbvie INC. | $101.42 | 2021-2024 | Avycaz, Teflaro |
| Baxter Healthcare | $100.46 | 2023-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Teva Pharmaceuticals USA, INC. | $95.78 | 2020-2021 | |
| Paratek Pharmaceuticals, INC. | $91.98 | 2020-2022 | |
| Electromed, INC. | $81.07 | 2022-2025 | Smartvest |
| Intuitive Surgical, INC. | $76.10 | 2023 | Da Vinci Surgical System |
| Circassia INC. | $59.50 | 2019 | |
| Novartis Pharmaceuticals Corporation | $57.72 | 2021-2024 | |
| Mallinckrodt Hospital Products INC. | $50.77 | 2021 | |
| Inspire Medical Systems, INC. | $49.78 | 2023-2025 | Inspire |
| Viatris Specialty LLC | $47.40 | 2025 | Yupelri |
| E.R. Squibb & Sons, L.L.C. | $43.30 | 2020-2021 | |
| Amgen INC. | $43.03 | 2025 | Tezspire |
| Harmony Biosciences LLC | $38.85 | 2023 | Wakix |
| Allergan, INC. | $33.88 | 2019-2020 | |
| Pfizer INC. | $28.59 | 2023 | |
| Phadia US INC. | $28.20 | 2022 | |
| Covis Pharma Gmbh | $25.06 | 2023 | |
| Gilead Sciences, INC. | $18.82 | 2022 | |
| Mayne Pharma Commercial LLC | $17.64 | 2021 | |
| Idorsia Pharmaceuticals US INC | $17.01 | 2023 | Quviviq |
| Lilly USA, LLC | $16.53 | 2025 | Zepbound |
| Itamar Medical INC | $16.35 | 2022 | |
| Optinose US, INC. | $14.56 | 2024 | |
| Inogen, INC. | $13.79 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Munif Salek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.